Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
16,132,569
-
Share change
-
-1,966,206
-
Total reported value
-
$158,574,277
-
Put/Call ratio
-
25%
-
Price per share
-
$9.87
-
Number of holders
-
69
-
Value change
-
-$27,806,994
-
Number of buys
-
35
-
Number of sells
-
36
Institutional Holders of KALA BIO INC COM NEW - Stock (KALA) as of Q3 2018
As of 30 Sep 2018,
KALA BIO INC COM NEW - Stock (KALA) was held by
69 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,132,569 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, LLC, Polaris Venture Management Co. V, L.L.C., WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., Vivo Capital, LLC, Vanguard Group Inc, PRICE T ROWE ASSOCIATES INC /MD/, WELLS FARGO & COMPANY/MN, and MILLENNIUM MANAGEMENT LLC.
This page lists
69
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.